Table 1.
Tiers of Somatic Profiling Test Results
| Tier | Description |
|---|---|
| Introduction | OncoMap test results will be tiered into three categories by disease center leaders and Personalized Cancer Medicine Partnership Executive Committee |
| One | Genomic variants proven to be clinically relevant (eg, validated, FDA approved, and/or actionable) |
| Two | Potentially actionable genomic variants (eg, nonvalidated or non–FDA approved but potentially actionable) |
| Three | All other genomic variants that do not fall under tier one or two |
Abbreviation: FDA, US Food and Drug Administration.